Protagenic Book Value Per Share from 2010 to 2024

PTIXW Stock

USD 0.01 0 11.11%

Protagenic Therapeutics Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share will likely drop to 0.80 in 2024. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Protagenic Therapeutics according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

0.84429726

Current Value

0.8

Quarterly Volatility

4.4 K

Credit Downgrade

Yuan Drop

Covid

Check Protagenic Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Protagenic Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 26.8 K, Interest Expense of 137.6 K or Selling General Administrative of 1.1 M, as well as many indicators such as Price To Sales Ratio of 0.28, Dividend Yield of 0.0 or PTB Ratio of 1.11. Protagenic financial statements analysis is a perfect complement when working with Protagenic Therapeutics Valuation or Volatility modules.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Latest Protagenic Therapeutics' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Protagenic Therapeutics over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Protagenic Therapeutics' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Protagenic Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0.83 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Protagenic Book Value Per Share Regression Statistics

	Arithmetic Mean	(2,126)
	Geometric Mean	8.18
	Coefficient Of Variation	(206.30)
	Mean Deviation	3,390
	Median	(0.08)
	Standard Deviation	4,386
	Sample Variance	19.2M
	Range	10.6K
	R-Value	0.70
	Mean Square Error	10.7M
	R-Squared	0.48
	Significance	0
	Slope	682.64
	Total Sum of Squares	269.3M

Protagenic Book Value Per Share History

	2024	0.8
	2023	0.84
	2022	1.6
	2021	2.7
	2020	-0.44
	2019	-0.25
	2018	-0.0822

Other Fundumenentals of Protagenic Therapeutics

Tangible Book Value Per Share

Protagenic Therapeutics Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Accounts Payable	Short Term Investments	Intangible Assets	Current Deferred Revenue	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Debt	Capital Surpluse	Short Long Term Debt
Total Assets		0.63	-0.02	0.19	-0.48	-0.48	-0.17	0.88	0.12	-0.24	-0.24	0.81	-0.27	0.57	0.73	0.73	0.11	-0.1	-0.09	-0.09
Total Stockholder Equity	0.63		-0.54	0.85	-0.16	-0.16	-0.87	0.64	-0.66	-0.9	-0.89	0.53	0.03	0.26	0.49	0.49	-0.03	0.07	-0.26	-0.26
Net Debt	-0.02	-0.54		-0.55	-0.42	-0.42	0.66	-0.23	0.68	0.61	0.61	-0.06	-0.43	0.32	-0.12	-0.12	0.16	0.02	0.38	0.38
Retained Earnings	0.19	0.85	-0.55		-0.13	-0.13	-0.98	0.15	-0.84	-0.99	-0.99	0.09	-0.07	0.15	0.06	0.06	-0.01	0.1	-0.04	-0.04
Net Receivables	-0.48	-0.16	-0.42	-0.13		1.0	-0.07	-0.04	-0.41	0.04	0.05	0.0	0.82	-0.95	0.15	0.15	-0.2	0.18	-0.41	-0.41
Good Will	-0.48	-0.16	-0.42	-0.13	1.0		-0.07	-0.04	-0.41	0.04	0.05	0.0	0.82	-0.95	0.15	0.15	-0.2	0.18	-0.41	-0.41
Total Liab	-0.17	-0.87	0.66	-0.98	-0.07	-0.07		-0.22	0.91	0.99	0.99	-0.15	-0.12	0.01	-0.16	-0.15	0.08	-0.12	0.17	0.17
Total Current Assets	0.88	0.64	-0.23	0.15	-0.04	-0.04	-0.22		-0.07	-0.25	-0.24	0.92	0.19	0.17	0.89	0.89	0.05	0.01	-0.37	-0.37
Short Term Debt	0.12	-0.66	0.68	-0.84	-0.41	-0.41	0.91	-0.07		0.86	0.86	-0.08	-0.32	0.41	-0.14	-0.14	0.03	-0.17	0.13	0.13
Common Stock	-0.24	-0.9	0.61	-0.99	0.04	0.04	0.99	-0.25	0.86		1.0	-0.16	-0.04	-0.1	-0.15	-0.14	0.07	-0.16	0.15	0.15
Accounts Payable	-0.24	-0.89	0.61	-0.99	0.05	0.05	0.99	-0.24	0.86	1.0		-0.15	-0.03	-0.11	-0.14	-0.14	0.07	-0.15	0.14	0.14
Short Term Investments	0.81	0.53	-0.06	0.09	0.0	0.0	-0.15	0.92	-0.08	-0.16	-0.15		0.07	0.04	0.98	0.98	0.12	-0.14	-0.12	-0.12
Intangible Assets	-0.27	0.03	-0.43	-0.07	0.82	0.82	-0.12	0.19	-0.32	-0.04	-0.03	0.07		-0.64	0.16	0.16	-0.24	0.3	-0.79	-0.79
Current Deferred Revenue	0.57	0.26	0.32	0.15	-0.95	-0.95	0.01	0.17	0.41	-0.1	-0.11	0.04	-0.64		-0.1	-0.1	0.05	-0.11	0.1	0.1
Net Invested Capital	0.73	0.49	-0.12	0.06	0.15	0.15	-0.16	0.89	-0.14	-0.15	-0.14	0.98	0.16	-0.1		1.0	0.12	-0.09	-0.17	-0.17
Net Working Capital	0.73	0.49	-0.12	0.06	0.15	0.15	-0.15	0.89	-0.14	-0.14	-0.14	0.98	0.16	-0.1	1.0		0.15	-0.09	-0.16	-0.16
Capital Stock	0.11	-0.03	0.16	-0.01	-0.2	-0.2	0.08	0.05	0.03	0.07	0.07	0.12	-0.24	0.05	0.12	0.15		-0.06	0.42	0.42
Long Term Debt	-0.1	0.07	0.02	0.1	0.18	0.18	-0.12	0.01	-0.17	-0.16	-0.15	-0.14	0.3	-0.11	-0.09	-0.09	-0.06		-0.27	-0.27
Capital Surpluse	-0.09	-0.26	0.38	-0.04	-0.41	-0.41	0.17	-0.37	0.13	0.15	0.14	-0.12	-0.79	0.1	-0.17	-0.16	0.42	-0.27		1.0
Short Long Term Debt	-0.09	-0.26	0.38	-0.04	-0.41	-0.41	0.17	-0.37	0.13	0.15	0.14	-0.12	-0.79	0.1	-0.17	-0.16	0.42	-0.27	1.0

Click cells to compare fundamentals

About Protagenic Therapeutics Financial Statements

Protagenic Therapeutics investors use historical fundamental indicators, such as Protagenic Therapeutics' Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Protagenic Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	0.84	0.80
Tangible Book Value Per Share	0.84	0.80

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Protagenic Stock Analysis

When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC